These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19367165)

  • 1. Oseltamivir and abnormal behaviors: true or not?
    Yorifuji T; Suzuki E; Tsuda T
    Epidemiology; 2009 Jul; 20(4):619-21. PubMed ID: 19367165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.
    Smith JR; Sacks S
    Int J Clin Pract; 2009 Apr; 63(4):596-605. PubMed ID: 19335705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is oseltamivir (Tamiflu) safe? Re-examining the Tamiflu 'ado' from Japan.
    Okamoto E
    Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):17-24. PubMed ID: 20121561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oseltamivir treatment for children showing abnormal behavior during influenza virus infection.
    Tanabe T; Hara K; Nakajima M; Shimakawa S; Tamai H
    Brain Dev; 2010 Jun; 32(6):440-4. PubMed ID: 19200672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated review.
    Toovey S; Prinssen EP; Rayner CR; Thakrar BT; Dutkowski R; Koerner A; Chu T; Sirzen-Zelenskaya A; Britschgi M; Bansod S; Donner B
    Adv Ther; 2012 Oct; 29(10):826-48. PubMed ID: 23054689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oseltamivir: neuropsychiatric disorders.
    Prescrire Int; 2007 Oct; 16(91):200. PubMed ID: 17926837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
    Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
    J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season.
    Kawai N; Ikematsu H; Iwaki N; Satoh I; Kawashima T; Maeda T; Miyachi K; Hirotsu N; Shigematsu T; Kashiwagi S
    Clin Infect Dis; 2005 May; 40(9):1309-16. PubMed ID: 15825034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons.
    Kawai N; Ikematsu H; Iwaki N; Maeda T; Satoh I; Hirotsu N; Kashiwagi S
    Clin Infect Dis; 2006 Aug; 43(4):439-44. PubMed ID: 16838232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oseltamivir: cutaneous and neurological adverse effects in children.
    Prescrire Int; 2006 Oct; 15(85):182-3. PubMed ID: 17128526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric concerns related to influenza treatment.
    Vantine M; Falahee ML; Vallerand AH
    Nurse Pract; 2009 Feb; 34(2):40-4. PubMed ID: 19155886
    [No Abstract]   [Full Text] [Related]  

  • 13. Abnormal behavior during influenza in Japan during the last seven seasons: 2006-2007 to 2012-2013.
    Nakamura Y; Sugawara T; Ohkusa Y; Taniguchi K; Miyazaki C; Momoi M; Okabe N
    J Infect Chemother; 2014 Dec; 20(12):789-93. PubMed ID: 25284815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescent jump case in Japan associated with influenza but not oseltamivir.
    Terada K; Kawai Y; Monju A; Wakabayashi T; Ouchi K
    Pediatr Infect Dis J; 2008 Jan; 27(1):88-9. PubMed ID: 18162953
    [No Abstract]   [Full Text] [Related]  

  • 15. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
    Nakamura K; Schwartz BS; Lindegårdh N; Keh C; Guglielmo BJ
    Clin Infect Dis; 2010 Apr; 50(7):e47-9. PubMed ID: 20192728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oseltamivir- related psychiatric manifestations.
    Guisado-Macías JA; Rodríguez FF; Méndez-Sánchez F; Bolívar-Perálvarez M
    Actas Esp Psiquiatr; 2012; 40(1):46-8. PubMed ID: 22344496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study.
    Nordstrom BL; Oh K; Sacks ST; L'Italien GJ
    Antivir Ther; 2004 Apr; 9(2):187-95. PubMed ID: 15134180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir.
    Kawai N; Ikematsu H; Iwaki N; Kawashima T; Maeda T; Mitsuoka S; Kondou K; Satoh I; Miyachi K; Yamaga S; Shigematsu T; Hirotsu N; Kashiwagi S
    J Infect; 2007 Sep; 55(3):267-72. PubMed ID: 17604839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral oseltamivir in human experimental influenza B infection.
    Hayden FG; Jennings L; Robson R; Schiff G; Jackson H; Rana B; McClelland G; Ipe D; Roberts N; Ward P
    Antivir Ther; 2000 Sep; 5(3):205-13. PubMed ID: 11075941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.